Deutsche Bank Aktiengesellschaft Cuts Universal Health Services (NYSE:UHS) Price Target to $230.00

Universal Health Services (NYSE:UHS) had its target price reduced by Deutsche Bank Aktiengesellschaft from $261.00 to $230.00 in a research report report published on Wednesday morning,MarketScreener reports. They currently have a buy rating on the health services provider’s stock.

A number of other equities research analysts also recently commented on the company. Wall Street Zen raised Universal Health Services from a “hold” rating to a “buy” rating in a report on Sunday, April 12th. Raymond James Financial downgraded Universal Health Services from an “outperform” rating to a “market perform” rating in a report on Wednesday. Guggenheim decreased their target price on Universal Health Services from $262.00 to $238.00 and set a “buy” rating for the company in a report on Monday, April 13th. Weiss Ratings downgraded Universal Health Services from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, April 17th. Finally, Robert W. Baird decreased their price target on Universal Health Services from $241.00 to $204.00 and set a “neutral” rating for the company in a report on Wednesday. Six analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Universal Health Services has a consensus rating of “Hold” and an average price target of $220.94.

Universal Health Services Trading Down 0.7%

Universal Health Services stock opened at $167.16 on Wednesday. The company has a quick ratio of 0.98, a current ratio of 1.08 and a debt-to-equity ratio of 0.52. Universal Health Services has a 52 week low of $152.33 and a 52 week high of $246.32. The company has a market capitalization of $10.21 billion, a price-to-earnings ratio of 6.97, a price-to-earnings-growth ratio of 0.72 and a beta of 1.13. The stock has a 50-day moving average price of $188.99 and a 200 day moving average price of $208.93.

Universal Health Services (NYSE:UHS) last released its earnings results on Monday, April 27th. The health services provider reported $5.62 EPS for the quarter, topping analysts’ consensus estimates of $5.41 by $0.21. Universal Health Services had a return on equity of 19.57% and a net margin of 8.56%.The firm had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.39 billion. During the same quarter in the previous year, the company posted $4.84 earnings per share. The company’s revenue was up 9.6% compared to the same quarter last year. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. Sell-side analysts anticipate that Universal Health Services will post 23.34 EPS for the current year.

Universal Health Services Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a $0.20 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.80 dividend on an annualized basis and a yield of 0.5%. Universal Health Services’s payout ratio is presently 3.33%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Pzena Investment Management LLC increased its position in shares of Universal Health Services by 31.5% in the fourth quarter. Pzena Investment Management LLC now owns 2,112,604 shares of the health services provider’s stock valued at $460,590,000 after buying an additional 505,575 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Universal Health Services by 6.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,588,911 shares of the health services provider’s stock valued at $346,447,000 after buying an additional 94,447 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Universal Health Services by 7.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,206,000 shares of the health services provider’s stock valued at $262,932,000 after buying an additional 80,236 shares in the last quarter. Norges Bank purchased a new stake in shares of Universal Health Services in the fourth quarter valued at approximately $199,334,000. Finally, Morgan Stanley increased its position in shares of Universal Health Services by 59.5% in the fourth quarter. Morgan Stanley now owns 871,377 shares of the health services provider’s stock valued at $189,978,000 after buying an additional 325,162 shares in the last quarter. 86.05% of the stock is owned by institutional investors and hedge funds.

Universal Health Services News Summary

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: UHS reiterated its full‑year 2026 volume targets despite softer seasonal volumes in Q1, signaling management confidence in recovery and that the Q1 hit may be temporary. Investors may view this as a stabilizing sign for guidance. UHS reaffirms 2026 volume targets
• Positive Sentiment: UHS deployed eight AI solutions in its revenue cycle in 2025 and is evaluating clinical operation use — potential margin upside and efficiency gains if rollouts scale. This supports longer‑term operating leverage. UHS deployed 8 AI solutions
• Neutral Sentiment: UHS is scheduled to present at the BofA Securities Health Care Conference (May 12). Management comments there could move shares if they provide clearer color on volumes, margins or M&A. UHS to present at BofA conference
• Neutral Sentiment: Analysts’ views are mixed on UHS relative to peers — differing takes may sustain volatility as investors parse which franchises (behavioral, acute, outpatient) will drive recovery. Analysts’ opinions mixed
• Negative Sentiment: Despite beating Q1 estimates, UHS shares fell after the quarter as investors focused on volume softness and the tone from the call rather than the beat — short‑term sentiment hurt. Why UHS is down after Q1
• Negative Sentiment: Coverage updates trimmed price targets: Stephens and Morgan Stanley lowered targets and kept “equal weight,” while several firms lowered targets (Mizuho, TD Cowen) even if ratings were maintained. Those revisions pressure sentiment and cap near‑term upside. Stephens price target cut Morgan Stanley price target cut
• Negative Sentiment: Q1 commentary/coverage noting that earnings growth was dampened by volume hits underscores the risk that patient volumes — not just pricing or cost control — will determine near‑term results. Q1 growth dampened by volume hits

About Universal Health Services

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.